ECL Stock Recent News

ST. PAUL, Minn.--(BUSINESS WIRE)--The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.57 per common share, to be paid October 15, 2024, to shareholders of record at the close of business on September 17, 2024. Ecolab has paid cash dividends on its common stock for 87 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions an.

Ecolab's (ECL) robust performance across the majority of its segments drives its second-quarter sales amid business challenges.

While the top- and bottom-line numbers for Ecolab (ECL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ecolab (ECL) came out with quarterly earnings of $1.68 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.24 per share a year ago.

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. (NYSE: ECL): SECOND QUARTER HIGHLIGHTS Reported sales $4.0 billion, +3% versus last year, including a 1% headwind from unfavorable foreign currency exchange. Organic sales +4% as Institutional & Specialty segment sales growth normalized to a strong +7% as expected. The segment lapped last year's very strong pricing delivery. Performance across the Pest Elimination, Industrial and Healthcare & Life Sciences segments all improved. Reported ope.

Get a deeper insight into the potential performance of Ecolab (ECL) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Ecolab's (ECL) second-quarter results are likely to reflect continued segmental strength.

In many parts of the world, it's either difficult for consumers and farmers to access enough fresh clean water, or it's getting significantly harder to do so. According to Fidelity, roughly 2 billion individuals worldwide are unable to obtain fresh drinking water.

DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities.

Ecolab Inc.  ECL has been gaining from its focus on research and development (R&D). The optimism, led by a solid first-quarter 2024 performance, along with its solid product portfolio, is expected to contribute further.